Previous close | 23.76 |
Open | 23.65 |
Bid | 23.85 x 200 |
Ask | 23.90 x 200 |
Day's range | 23.48 - 23.87 |
52-week range | 22.01 - 33.71 |
Volume | |
Avg. volume | 1,976,095 |
Market cap | 4.035B |
Beta (5Y monthly) | 0.55 |
PE ratio (TTM) | 7.79 |
EPS (TTM) | 3.06 |
Earnings date | 01 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 35.55 |
The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.
Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Wednesday, May 1, 2024 to discuss the company's first quarter financial results.
Alkermes (ALKS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.